By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Abbott said this week that its Abbott Molecular business has received the CE Mark for its first DNA sequencing assay developed and introduced by the firm. The Abbott HBV Sequencing test has been developed to identify genomic sequences of the hepatitis B virus. Abbott said that the test is not intended for screening blood donors, plasma, or tissue donors for HBV, or to be used as a diagnostic test to confirm the presence of HBV infection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.